OpenBilldrug price receipt

NADAC week of 2026-10-14

COTEMPLA XR-ODT 25.9 MG TABLET

FDA nonproprietary name: methylphenidate

For 30 tablets

Pharmacies pay

$539.14 filed

30 × $17.97122 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$499.49 filed

30 × $16.64974 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.93× estimated

Medicare paid 7% less than pharmacies pay.

Part D averages every strength and form sold under “Cotempla XR-ODT” / “Methylphenidate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$625.01 estimated

$539.14 + $80.87 (15%) + $5.00 fee per fill = $625.01

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

COTEMPLA XR-ODT 25.9 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methylphenidate, under the trade name “Cotempla XR-ODT”.

FDA gives its dosage form as tablet, orally disintegrating and its route as oral.

The labeler, the company named on the label, is Neos Therapeutics Brands, LLC.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70165-0300-30.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $539.14 for 30 tablets (30 × $17.97122 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name methylphenidate with COTEMPLA XR-ODT 25.9 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
COTEMPLA XR-ODT 8.6 MG TABLET
brand · tablet, orally disintegrating
$18.04904 per EA filed
eff. 2026-09-23
$16.64974 per EA filed
Part D 2024 average
COTEMPLA XR-ODT 17.3 MG TABLET
brand · tablet, orally disintegrating
$17.89343 per EA filed
eff. 2026-09-23
$16.64974 per EA filed
Part D 2024 average
COTEMPLA XR-ODT 25.9 MG TABLET this page
brand · tablet, orally disintegrating
$17.97122 per EA filed
eff. 2026-09-23
$16.64974 per EA filed
Part D 2024 average
METHYLPHENIDATE 10 MG/9 HR PATCH
generic · patch
$6.66369 per EA filed
eff. 2026-09-23
$9.71315 per EA filed
Part D 2024 average
METHYLPHENIDATE 15 MG/9 HR PATCH
generic · patch
$6.63292 per EA filed
eff. 2026-09-23
$9.71315 per EA filed
Part D 2024 average
METHYLPHENIDATE 20 MG/9 HR PATCH
generic · patch
$6.60924 per EA filed
eff. 2026-09-23
$9.71315 per EA filed
Part D 2024 average
METHYLPHENIDATE 30 MG/9 HR PATCH
generic · patch
$7.25282 per EA filed
eff. 2026-09-23
$9.71315 per EA filed
Part D 2024 average
METHYLPHENIDATE ER(LA) 10 MG CP
generic · capsule, extended release
$2.39986 per EA filed
eff. 2026-09-23
$3.41274 per EA filed
Part D 2024 average
METHYLPHENIDATE ER(LA) 20 MG CP
generic · capsule, extended release
$1.69545 per EA filed
eff. 2026-09-23
$3.41274 per EA filed
Part D 2024 average
METHYLPHENIDATE ER(LA) 30 MG CP
generic · capsule, extended release
$1.90366 per EA filed
eff. 2026-09-23
$3.41274 per EA filed
Part D 2024 average
METHYLPHENIDATE ER(LA) 40 MG CP
generic · capsule, extended release
$1.85373 per EA filed
eff. 2026-09-23
$3.41274 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $17.97122 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 10 have a higher middle NADAC price and 193 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $499.49 for 30 tablets, at an average of $16.64974 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cotempla XR-ODT” and “Methylphenidate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 238 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for COTEMPLA XR-ODT 25.9 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cotempla XR-ODT / Methylphenidate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.